By Sally Chew MONDAY, Dec. 15, 2008 (Health.com)--
Women at high risk for breast cancer are generally advised to have one mammogram and one magnetic resonance image (MRI) scan every year, and they usually schedule them around the same time, along with a hands - on examination by a doctor.
Women at high risk for breast cancer may also be screened with other imaging tests, like a breast MRI.
This rate compares favorably with hormonal treatments such as tamoxifen given as a preventive measure to
women at high risk for breast cancer.
End cost - sharing for diagnostic imaging for breast cancer, including diagnostic mammograms, breast ultrasounds, and breast MRIs for
women at high risk for breast cancer.
These findings suggest new indicators for identifying
women at higher risk for breast cancer and provide insights into potential new strategies to detect, treat, and prevent the disease.
Not exact matches
«Mayo Clinic is now developing new studies that will focus on the role of CDK 4/6 inhibitors and their potential to inhibit
cancer metastasis in
women with triple - negative
breast cancer who are
at highest risk for cancer metastasis.»
Women with a family history of two or more immediate family members (mother, sister, daughter) with
breast or ovarian
cancer or with a positive genetic test
for mutations in the BRCA1 or BRCA2 genes may be advised to consider having both
breasts removed, because they are
at high risk of a new
cancer developing in the other
breast.
«Instead of only telling
women that they don't have
cancer, we could test the biopsies and tell
women if they were
at high risk or low
risk for developing
breast cancer in the future,» said Polyak, a
breast cancer researcher
at Dana - Farber and co-senior author of the paper.
Among postmenopausal
women with normal body mass index (BMI), those with
higher body fat levels had an increased
risk for invasive
breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27
cancer, according to data presented
at the American Association
for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27
Cancer Research Special Conference Obesity and
Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27
Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27 - 30.
For some
cancers like
breast cancer occurring in younger
women before the menopause, there even seemed to be a lower
risk at higher BMI.
Launched in 1993, the
Women's Health Initiative halted a Prempro test in July 2002 when researchers discovered that women taking the drug were at a higher risk for developing breast cancer, heart attacks, blood clots, and str
Women's Health Initiative halted a Prempro test in July 2002 when researchers discovered that
women taking the drug were at a higher risk for developing breast cancer, heart attacks, blood clots, and str
women taking the drug were
at a
higher risk for developing
breast cancer, heart attacks, blood clots, and strokes.
Seventy - five percent of
women diagnosed with
breast cancer have no family history or other factors that place them
at high risk for the disease.
Used in conjunction with mammography, imaging based on nuclear medicine is currently being used as a successful secondary screening alongside mammography to reduce the number of false positive results in
women with dense
breasts and
at higher risk for developing
breast cancer.
It has long been known that
women with denser
breasts are
at higher risk for breast cancer.
«The
higher risk of tumor recurrence that we observed among African American
women was reduced when controlling
for those factors, suggesting that these genomic differences contribute,
at least partly, to the known racial disparity in the survival of African American and Caucasian
breast cancer patients.»
This may help explain why
women with dense
breasts are also
at higher risk for breast cancer.
Women who are most anxious about the possibility of developing
breast cancer are least likely to attend a screening programme designed
for those
at high risk.
Olopade has a special interest in
breast cancers that are difficult to treat and in
women at high risk for this malignancy.
Until now, there has been limited information about whether it reduces
breast cancer risk for women who are
at the very
highest level of
risk with BRCA1 or BRCA2.
Presentations included: Genetics Primer & Clinical Updates by Linford Williams, MS, LGC; Genetics and
Women's Health: Seeing and Foreseeing the Ethical Challenges Ahead by Ruth Farrell, MD, MA; Preimplantation Genetic Screening and Diagnosis: What You Need to Know by Marissa Coleridge, MS, LGC; Evolution of Prenatal Genetic Screening and Testing: NIPT and Beyond by Jeff Chapa, MD, MBA; Promises and Pitfalls of Prenatal Whole Exome Sequencing by Amanda Kalan, MD; Fertility Preservation and
Cancer: Survivors, Previvors, and the Newly Diagnosed by Rebecca Flyckt, MD; Improving Access to
Cancer Genetics via Telegenetics by Ryan Noss, MS, LGC;
Breast Cancer: Management of Moderate Penetrance Predisposition Genes by Holly Pederson, MD; Use of Hormonal and Non-hormonal Therapies in
Breast Cancer Survivors and
Women at High Risk for Breast / Gyn
Cancers by Holly Thacker, MD; Addressing Commonly Asked Patient Questions about Genetics by Rebekah Moore, MS, LGC, Christina Rigelsky, MS, LGC and Allison Schreiber, MS, LGC; and a panel discussion on Genetic Testing Reimbursement featuring Bruce Rogen, MD, MPH and John Yao, MD, MBA, MPH, which was moderated by Daniel Sullivan, MD..
Now, a study published in the August 2014 issue of
Cancer Research states that women taking birth control pills are at higher risk for breast cancer, and that the risk depends on the amount of estrogen in that particular
Cancer Research states that
women taking birth control pills are
at higher risk for breast cancer, and that the risk depends on the amount of estrogen in that particular
cancer, and that the
risk depends on the amount of estrogen in that particular pill.
• Limit alcohol to one drink per day (
women who are
at high risk for breast cancer should consider not drinking alcohol
at all).
More Evidence that Vitamin D Protects Against
Breast Cancer A new study shows that women with low vitamin D levels are at a higher risk for breast cancer, but women on HRT aren't as well prot
Breast Cancer A new study shows that women with low vitamin D levels are at a higher risk for breast cancer, but women on HRT aren't as well prot
Cancer A new study shows that
women with low vitamin D levels are
at a
higher risk for breast cancer, but women on HRT aren't as well prot
breast cancer, but women on HRT aren't as well prot
cancer, but
women on HRT aren't as well protected.
Research shows healthy
women at high risk of
breast cancer who took the medication
for four - and - a-half years lowered their
breast density by 6.4 percent, Diorio relates.
It was Lindsay's hope to turn her experiences as a young
woman at high risk for breast and ovarian
cancer into a resource and supportive community
for other young
women.
It was during my journey that I realized the lack of resources
for women in my specific situation — young
women who weren't survivors but were
at high risk for developing
breast and ovarian
cancer and those who wanted to take charge of their health.
There were so many resources
for breast and ovarian
cancer survivors but none specifically
for young
women at high -
risk.